As Malware Infection Rates Rise, Triumfant is Tamiflu for the Endpoint

I am writing today from the guest bedroom in our home, where I have been living since arriving home from the McAfee FOCUS 09 show in Las Vegas late Friday evening.  Turns out that my steadily declining physical state that started the moment I was dropped off at the LV airport was the onset of the flu. 

Spending now four days in quarantine gives one plenty of time to reflect and think.  Like just how much I really missed HD TV over a football filled weekend.  Or how much I really enjoyed zipping around Las Vegas Motor Speedway at 150+ mph in a “retired” Sprint Cup race car at the McAfee User party Thursday night at the conference. Or how glad I am that they invented Tamiflu.

Thank you, Tamiflu. In these days of flu shot stories and an emphasis on preventing the virus from taking root, I am real glad that someone also spent the effort to develop a drug that quickly eradicated the flu if it managed to evade all of the defensive precautions and find a home in your body.  Saturday I was a shivering, hacking, fevered glob of goo.  But thanks to quick diagnosis and immediate application of Tamiflu, I was back to being very close to normal (for me) by noon Sunday.  No more aches, no more fever, no more chills.  Prevention is a laudable goal, but thankfully there are pragmatic types that understand that something must also be in place when prevention does not work

Of course, there is a parallel here in regards to Triumfant.  No matter how much people try to keep bad things from endpoint machines, the bad things are making it to these machines in increasing frequency.  Just look at today where Microsoft came out with patches for over 34 vulnerabilities, many of which already have exploits in the wild.  The McAfee conference featured the McAfee suite of products plus 81 partners all trying a wide variety of ways to protect networks and machines from being infected, but every speaker noted that infection rates have never been higher. 

This is the world in which IT Security must function – there is no magic flu shot for the endpoint. In spite of the best efforts by really smart people to shield machines from infection, malware gets through and turns them into the silicon equivalent of shivering, hacking, fevered globs of goo.  And that is where Triumfant excels, because it will see such an attack, perform a diagnosis and build a Tamiflu injection in the form of a situational remediation. From infection to cure in 5 minutes or less.  Furthermore,  it does so if this is a known problem or an entirely new problem because it does not rely on prior knowledge of an attack to do its job.

And best of all, your computer does not have to spend a week in the guest room without HD TV.

About Jim Ivers
Jim Ivers is the Chief Security Strategist at Triumfant

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 409 other followers